English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Background Patients treated for breast cancer have a high incidence of cardiovascular complications. In this study, we evaluated the impact of breast cancer on cardiac function and cardiomyocyte Ca2+ ‐handling protein expression. We also investigated whether exercise training (ET) would prevent these potential alterations.Methods and Results Transgenic mice with spontaneous breast cancer (mouse mammary tumor virus–polyomavirus middle T antigen [MMTV‐PyMT+], n=15) and littermate mice with no cancer (MMTV‐PyMT−, n=14) were studied. For the ET analysis, MMTV‐PyMT+ were divided into sedentary (n=10) and exercise‐trained (n=12) groups. Cardiac function was evaluated by echocardiography with speckle‐tracking imaging. Exercise tolerance test was conducted on a treadmill. Both studies were performed when the tumor became palpable and when it reached 1 cm3 . After euthanasia, Ca2+ ‐handling protein expression (Western blot) was evaluated. Exercise capacity was reduced in MMTV‐PyMT+ compared with MMTV‐PyMT− (P interaction =0.031). Longitudinal strain (P group &lt;0.001) and strain rate (P group =0.030) were impaired. Cardiomyocyte phospholamban was increased (P =0.011), whereas phospho‐phospholamban and sodium/calcium exchanger were decreased (P =0.038 andP =0.017, respectively) in MMTV‐PyMT+. No significant difference in sarcoplasmic or endoplasmic reticulum calcium 2 ATPase (SERCA2a) was found. SERCA2a/phospholamban ratio was reduced (P =0.007). ET was not associated with increased exercise capacity. ET decreased left ventricular end‐systolic diameter (P group =0.038) and end‐diastolic volume (P group =0.026). Other morphological and functional cardiac parameters were not improved by ET in MMTV‐PyMT+. ET did not improve cardiomyocyte Ca2+ ‐handling protein expression.Conclusions Breast cancer is associated with decreased exercise capacity and subclinical left ventricular dysfunction in MMTV‐PyMT+, which is at least partly associated with dysregulation of cardiomyocyte Ca2+ handling. ET did not prevent or reverse these changes.

journal of the american heart association. cardiovascular and cerebrovascular disease

Breast Cancer Promotes Cardiac Dysfunction Through Deregulation of Cardiomyocyte Ca <sup>2+</sup> ‐Handling Protein Expression That is Not Reversed by Exercise Training

Breast Cancer Promotes Cardiac Dysfunction Through Deregulation of Cardiomyocyte Ca 2+ ‐Handling Protein Expression That is Not Reversed by Exercise Training

Breast Cancer Promotes Cardiac Dysfunction Through Deregulation of Cardiomyocyte Ca ²⁺ ‐Handling Protein Expression That is Not Reversed by Exercise Training